Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP7

SUPPRESSTEM

Project reference: 601876
Funded under

Testing and validation of bispecific antibody combinations targeting treatment-resistant cancer stem cells using organoid-based screening tools: a new drug discovery paradigm

From 2013-06-01 to 2016-11-30, ongoing project | SUPPRESSTEM Website

Project details

Total cost:

EUR 7 756 658,4

EU contribution:

EUR 5 953 319

Coordinated in:

Netherlands

Call for proposal:

FP7-HEALTH-2013-INNOVATION-2See other projects for this call

Funding scheme:

CP-FP - Small or medium-scale focused research project

Objective

Related information

Coordinator

MERUS BV
Netherlands

EU contribution: EUR 3 229 540,6


PADUALAAN 8 133
3584CH UTRECHT
Netherlands
Administrative contact: Shelley Margetson
Tel.: +31 2538800
Fax: +31 2538677
E-mail

Participants

KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW
Netherlands

EU contribution: EUR 1 122 911


KLOVENIERSBURGWAL 29 HET TRIPPENHUIS
1011 JV AMSTERDAM
Netherlands
Administrative contact: Don Van Velzen
Tel.: +31 030 2121 800
E-mail
OCELLO BV
Netherlands

EU contribution: EUR 892 151


J H OORTWEG LEIDEN BIOPARTNER 21
2333 CH LEIDEN
Netherlands
Administrative contact: Leo Price
Tel.: +31618968358
E-mail
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
Spain

EU contribution: EUR 338 346,8


CARRER BALDIRI REIXAC 10-12 PARC SCIENTIFIC DE BARCELONA
08028 BARCELONA
Spain
Administrative contact: Raquel Furio
Tel.: +34 93 402 02 50
E-mail
GENOME RESEARCH LIMITED
United Kingdom

EU contribution: EUR 370 369,6


THE GIBBS BUILDING, EUSTON ROAD 215
NW1 2BE LONDON
United Kingdom
Administrative contact: David Davison
Tel.: +44 1223494937
E-mail

Subjects

Life Sciences
Record Number: 108696 / Last updated on: 2016-06-13